Back to catalogue
TERN
Tern PLC
430/1000 Overall fit
AI beneficiary 35% 38
Operating leverage 25% 42
Valuation 25% 46
Downside protection 15% 51
First-pass take
Early-stage IoT VC fund with one genuinely AI-focused investment (Talking Medicines) but diversified across security, industrial IoT, and healthcare tech. Positions for long-term digital transformation rather than near-term AI spending. Net cash, trading at NAV. Portfolio grew 18% but recent fundraises dilute shareholders.
Flags
micro-capvc-modelgrowth-stagehigh-dilution